Free tool

Rare disease stocks

We cover 15 companies grouped under the Rare disease theme. The median market value in the group is $721.17M. Across the group, the median move over the past trading day is +0.03%. Price change over the past year runs from +38.1% to +669.1% across the middle 80 percent of the group, with a median of +179.1%.

Other lists in this group

Table

15 of 268 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y return
CRNXCrinetics Pharmaceuticals, Inc.$9.00BMid cap+179.08%
AMLXAmylyx Pharmaceuticals, Inc.$4.13BMid cap+292.38%
CPRXCatalyst Pharmaceuticals Inc$3.85BMid cap+55.97%
ETONEton Pharmaceuticals, Inc.$1.79BSmall cap+262.38%
FBRXForte Biosciences, Inc.$1.63BSmall cap+589.87%
KALVKalVista Pharmaceuticals Inc$1.44BSmall cap+98.68%
OMEROmeros Corporation$1.40BSmall cap+328.71%
ASMBAssembly Biosciences, Inc.$721.17MSmall cap+36.81%
AQSTAquestive Therapeutics, Inc.$676.51MSmall cap+40.00%
CRDLCardiol Therapeutics Inc.$250.00MSmall cap+91.07%
SPRBSpruce Biosciences, Inc.$176.69MSmall cap+721.93%
CPIXCumberland Pharmaceuticals Inc.$130.35MSmall cap+163.82%
VYNEVYNE Therapeutics Inc$19.07MMicro cap+8660.74%
CMMBChemomab Therapeutics Ltd.$16.85MMicro cap−25.57%
GLMDGalmed Pharmaceuticals Ltd.$4.48MMicro cap+211.51%

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse